These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7666526)
1. In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. Jamieson BD; Pang S; Aldrovandi GM; Zha J; Zack JA J Virol; 1995 Oct; 69(10):6259-64. PubMed ID: 7666526 [TBL] [Abstract][Full Text] [Related]
2. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. Jamieson BD; Aldrovandi GM; Planelles V; Jowett JB; Gao L; Bloch LM; Chen IS; Zack JA J Virol; 1994 Jun; 68(6):3478-85. PubMed ID: 8189487 [TBL] [Abstract][Full Text] [Related]
3. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892 [TBL] [Abstract][Full Text] [Related]
4. Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. Kaneshima H; Su L; Bonyhadi ML; Connor RI; Ho DD; McCune JM J Virol; 1994 Dec; 68(12):8188-92. PubMed ID: 7966610 [TBL] [Abstract][Full Text] [Related]
5. High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. Jamieson BD; Uittenbogaart CH; Schmid I; Zack JA J Virol; 1997 Nov; 71(11):8245-53. PubMed ID: 9343176 [TBL] [Abstract][Full Text] [Related]
6. Thymocyte and thymic microenvironment alterations during a systemic HIV infection in a severe combined immunodeficient mouse model. Autran B; Guiet P; Raphael M; Grandadam M; Agut H; Candotti D; Grenot P; Puech F; Debre P; Cesbron JY AIDS; 1996 Jun; 10(7):717-27. PubMed ID: 8805862 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739 [TBL] [Abstract][Full Text] [Related]
8. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. Moffat JF; Stein MD; Kaneshima H; Arvin AM J Virol; 1995 Sep; 69(9):5236-42. PubMed ID: 7636965 [TBL] [Abstract][Full Text] [Related]
9. Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus. Duus KM; Miller ED; Smith JA; Kovalev GI; Su L J Virol; 2001 Apr; 75(8):3916-24. PubMed ID: 11264380 [TBL] [Abstract][Full Text] [Related]
10. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy. Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895 [TBL] [Abstract][Full Text] [Related]
11. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans. Bonyhadi ML; Kaneshima H Mol Med Today; 1997 Jun; 3(6):246-53. PubMed ID: 9211415 [TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication. Camerini D; Su HP; Gamez-Torre G; Johnson ML; Zack JA; Chen IS J Virol; 2000 Apr; 74(7):3196-204. PubMed ID: 10708436 [TBL] [Abstract][Full Text] [Related]
13. Identification of HIV-1 determinants for replication in vivo. Su L; Kaneshima H; Bonyhadi ML; Lee R; Auten J; Wolf A; Du B; Rabin L; Hahn BH; Terwilliger E; Mccune JM Virology; 1997 Jan; 227(1):45-52. PubMed ID: 9007057 [TBL] [Abstract][Full Text] [Related]
14. Persistent infection of macaques with simian-human immunodeficiency viruses. Li JT; Halloran M; Lord CI; Watson A; Ranchalis J; Fung M; Letvin NL; Sodroski JG J Virol; 1995 Nov; 69(11):7061-7. PubMed ID: 7474126 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver. Kollmann TR; Pettoello-Mantovani M; Katopodis NF; Hachamovitch M; Rubinstein A; Kim A; Goldstein H Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3126-31. PubMed ID: 8610180 [TBL] [Abstract][Full Text] [Related]
16. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. Pettoello-Mantovani M; Kollmann TR; Raker C; Kim A; Yurasov S; Tudor R; Wiltshire H; Goldstein H Antimicrob Agents Chemother; 1997 Sep; 41(9):1880-7. PubMed ID: 9303378 [TBL] [Abstract][Full Text] [Related]
17. A Simple Mouse Model for the Study of Human Immunodeficiency Virus. Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392 [TBL] [Abstract][Full Text] [Related]
18. Infection of the SCID-hu mouse by HIV-1. Namikawa R; Kaneshima H; Lieberman M; Weissman IL; McCune JM Science; 1988 Dec; 242(4886):1684-6. PubMed ID: 3201256 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. Scoggins RM; Taylor JR; Patrie J; van't Wout AB; Schuitemaker H; Camerini D J Virol; 2000 Apr; 74(7):3205-16. PubMed ID: 10708437 [TBL] [Abstract][Full Text] [Related]
20. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. Joag SV; Li Z; Foresman L; Stephens EB; Zhao LJ; Adany I; Pinson DM; McClure HM; Narayan O J Virol; 1996 May; 70(5):3189-97. PubMed ID: 8627799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]